Truveta

News

Truveta's co-founder and chief executive, Terry Myerson

Regeneron, Illumina join $320m Truveta investment

Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project.

News

Pfizer is first big pharma to tap Truveta's real-world data ...

Pfizer has harnessed the expertise of health data specialist Truveta to provide close monitoring of safety and other signals for its products, including COVID-19 vaccine Comirnaty, almost i

News

Novartis snaps up PI3Kα breast cancer drug in $3bn deal

Novartis has agreed to buy a PI3Kα-targeting drug for breast cancer from Synnovation, a potential successor to its Piqray brand, for $2bn upfront.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Editor's Picks